Duavent Pulmoneb
Formulation
Each 2.5 mL pulmoneb contains:
Ipratropium bromide (anhydrous) 500 mcg
Salbutamol (as sulfate) 2.5 mg

Ipratropium Salbutamol

Duavent® PulmoNeb®

Prescription Drug

Indication

  • Management of reversible bronchospasm associated with obstructive airway diseases (e.g., bronchial asthma)
  • For use in patients with chronic obstructive pulmonary disease (COPD) on a regular inhaled bronchodilator who continue to have evidence of bronchospasm and who require a second bronchodilator.

Dosage and Administration

For more information on safety, precaution and other information about this product, please see the Product Insert.

Please consult your physician and other healthcare providers before taking any prescription medicines found on this site. The contents found on this page are for information purposes only. It should not be construed as a substitute for professional medical advise and should not be relied upon in that regard. You undertake to carefully read all product packaging and labels prior to use.

Caution: Food, Drugs, Devices and Cosmetics Act prohibits dispensing without prescription.